Kassebaum's S 1477 focuses on improved FDA processes rather than third-party reviews.
This article was originally published in The Tan Sheet
Executive Summary
KASSEBAUM URGES IMPROVED FDA REGULATORY PROCESS INSTEAD OF THIRD PARTY reviews in a Dec. 14 interview on National Public Radio's "Diane Rehm Show." Senate Labor & Human Resources Committee Chairman Nancy Kassebaum (R-Kan.) suggested that Congress should focus on improving the agency's regulatory procedures rather than on contracting outside third parties for application reviews.